RocaJunyent Guides Nina Capital Launch in Medical Tech Sector

The venture capital firm Nina Capital brings its third fund to the market after having raised a total of €300 million and €60 million of its own investments in almost fifty start-ups in the medical technology sector.

In five years, Nina Capital has positioned itself as an international benchmark in the venture capital sector in areas such as digital health and medical technologies. The company achieved a 70% repetition rate with its previous investment vehicle and has invested around sixty million euros in almost fifty early-stage companies in the last five years.

RocaJunyent‘s Banking and Finance team, led by partner Xavier Foz (pictured left), associate director Jordi Bermúdez (pictured centre), and Marc Rovira Solé (pictured right), played a key role in advising on the establishment of Nina Capital Fund III, securing a substantial €50 million.